Short Communication
Volume 6 Issue 8 - 2018
Adverse Drug Reactions Associated with Blood and its Transfusion: A Brief Report
Pramod Kumar, Ismeet Kaur* and V Kalaiselvan
Department of Pharmacovigilance , PvPI, Govt. of India
*Corresponding Author: Ismeet Kaur, Department of Pharmacovigilance, PvPI, Govt. of India.
Received: June 04, 2018; Published: July 06, 2018
Citation: “Adverse Drug Reactions Associated with Blood and its Transfusion: A Brief Report”. EC Pharmacology and Toxicology 6.8 (2018): 651-654.
Indian Pharmacopoeia Commission has started Haemovigilance Program of India (HvPI) in 2012 under the umbrella of Pharmacovigilance Program of India (PvPI) in collaboration with National Institute of Biologicals (NIB), Noida, Uttar Pradesh, under Ministry of Health and Family welfare, Government of India with a primary objective to track adverse reactions/events and incidences associated with blood transfusion and blood product administration and to identify trends, recommend best practices and interventions required to improve patient care and safety.
Keywords: Adverse Drug Reactions; Blood; Transfusion
Copyright: © 2018 Ismeet Kaur., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

News and Events

Welcoming Article Submission

ECronicon delightfully welcomes the authors for submission of articles towards the upcoming issue of respective journals.

Submission Timeline

Last date for submission of articles is December 31, 2018.

Publication Certificate

Authors will be issued a "Publication Certificate" as a token of appreciation for publishing their work.

Best Article of the Issue

The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue".

Visitors: 3276953